Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04513301
Status:
UNKNOWN
Last Update Posted:
2020-08-14
First Post:
2020-08-12
Brief Title:
Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC EGFR - ALK - After Failure of Platinum-based Chemotherapy A RandomizedOpen Labled Phase II Clinical Study
Sponsor:
Organization:
Shanghai Cancer Hospital China